Sökresultat
SCANPROST Meeting: A Scandinavian meeting to discuss recent developments in prostate cancer
…not cover the cost of either travel or accommodation. For this reason, each participant is responsible for booking and paying its own travel and accommodation. Remember: the participant is responsible for the employer’s approval to participate in the meeting. For questions regarding registration, contact: Karin Ekenberg, Business Operations Specialist Janssen Email: [email protected].com Phone: +46 73 665 39 84 For questions regarding the event, co…
Intensified treatment options and considerations in mHSPC
…Dr Niilo Hendolin (Finland), Dr Marius Kinčius (Lithuania) Agenda 12:00 Welcome and introduction – setting the Nordic scene (Daniel Heinrich) 12:10 The role of intensified treatment in mHSPC patients – identification of the right treatment option for the right patient (Matthew R. Smith) 12:50 Panel discussion and live Q&A (All) 13:15 Meeting closure For assistance regarding registration please contact; Carina Bajer, Business Support Specialist, ca…
Libtayo som monoterapi ökar totalöverlevnaden i första linjens behandling av avancerad NSCLC
…lly advanced disease that had progressed after definitive chemoradiation. Patients whose disease progressed in the trial were able to change their therapy: those in the chemotherapy arm were allowed to crossover into the cemiplimab arm, while those in the cemiplimab arm were allowed to combine cemiplimab treatment with 4 to 6 cycles of chemotherapy. A prespecified interim analysis was performed after 50% of OS events. Due to a highly significant i…
mRNA-baserade HPV-test kan leda till lägre kostnader och färre onödiga kolposkopier
…rutöver, menar forskarna, skulle tiotusentals uppföljningar med HPV- och cytologitest kunna undvikas. Elisabeth Adams erinrar om att resultaten av modelleringsstudier som denna påverkas av flera faktorer såsom vilken algoritm man väljer varför besparingens faktiska storlek kan skilja sig något från den beräknade och att man därför inte ska fästa så stor vikt vid de exakta siffrorna. – Likväl menar vi att detta kan generera fördelar för såväl kvinn…
Talzenna den första PARP-hämmaren som subventioneras för BRCA-muterad bröstcancer
…k Force Recommendation [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Dec. Report No.: 12-05164-EF-1. Meynard G, Villanueva C, Thiery-Vuillemin A, et al. Real-life study of BRCA genetic screening in metastatic breast cancer. Annals of Oncology. 2017; Volume 28, Issue suppl_5, mdx365.047. Fasching PA, Hu C, Hart SN, et al. Cancer predisposition genes in metastatic breast cancer – association with metastatic patter…